Overview

Raised this Round: Raised: $240,434

Total Commitments ($USD)

Platform

Dealmaker Securities

Start Date

06/12/2024

Close Date

07/02/2024

Min. Goal
$10,143
Max. Goal
$1,014,300
Min. Investment

$293

Security Type

Equity - Common

Series

Series B

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$11.27

Early Bird Valuation

$60,571,429

Pre-Money Valuation

$106,000,000

Year Founded

2019

Industry

Fitness & Wellness

Tech Sector

Medtech

Distribution Model

B2B/B2C

Margin

High

Capital Intensity

Low

Location

Brooklyn, New York

Business Type

Growth

Fisher Wallace Labs, with a valuation of $106 million, is raising funds on DealMaker. The company is building and commercializing wearable brain stimulation technology for the rapid treatment of anxiety, depression, insomnia, and other neuropsychiatric and cognitive disorders. Under temporary FDA clearance, Fisher Wallace commercialized its proof-of-concept Version 1.0 device. Fisher Wallace has sold over 100,000 units and the results of their depression trial were published in The Journal of Clinical Psychiatry. Charles Fisher founded Fisher Wallace Labs in 2019. The current crowdfunding campaign has a minimum target of $10,143 and a maximum target of $1,014,300. The campaign proceeds will be used for clinical research, regulatory consulting & legal fees, manufacturing, product development, and operations.

Summary Profit and Loss Statement

FY 2022 FY 2021

Revenue

$4,739,387

$4,230,290

COGS

$1,096,113

$623,703

Tax

$0

$250

 

 

Net Income

$-7,073,744

$3,262,291

Summary Balance Sheet

FY 2022 FY 2021

Cash

$128,229

$1,929,380

Accounts Receivable

$0

$0

Total Assets

$439,495

$1,999,403

Short-Term Debt

$427,470

$471,468

Long-Term Debt

$1,083,664

$576,525

Total Liabilities

$1,511,134

$1,047,993

Financials as of: 06/12/2024
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Fisher Wallace 07/01/2024 Dealmaker Securities $106,000,000 $240,434 Equity - Common Funded RegCF
Fisher Wallace 04/17/2024 Dealmaker Securities $104,100,000 $413,448 Equity - Common Funded RegCF
Fisher Wallace 03/11/2024 Dealmaker Securities $102,658,809 $469,069 Equity - Common Funded RegCF
Fisher Wallace 01/23/2024 Dealmaker Securities $102,170,000 $532,202 Equity - Common Funded RegCF
Fisher Wallace Laboratories 10/03/2023 StartEngine $100,280,000 $493,354 Equity - Common Funded RegA+
Fisher Wallace 02/19/2023 StartEngine $81,567,588 $1,281,201 Equity - Common Funded RegCF
Fisher Wallace Laboratories 08/31/2022 StartEngine $81,236,323 $357,719 Equity - Common Funded RegCF
Fisher Wallace Laboratories 05/26/2022 StartEngine $80,048,889 $1,279,724 Equity - Common Funded RegCF
Fisher Wallace Laboratories 10/25/2021 StartEngine $40,000,000 $5,010,683 Equity - Common Funded RegA+
Fisher Wallace Laboratories 03/08/2020 StartEngine $15,000,000 $1,056,480 Equity - Common Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Fisher Wallace Labs
Platform: Dealmaker Securities
Security Type: Equity - Common
Valuation: $106,000,000
Price per Share: $11.27

Follow company

Follow Fisher Wallace Labs

Buy Fisher Wallace's Deal Report

Warning: according to the close date for this deal, Fisher Wallace may no longer be accepting investments.

Fisher Wallace Deal Report

Get KingsCrowd’s comprehensive report on Fisher Wallace including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Fisher Wallace is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Fisher Wallace deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge